Abstract:Ferroptosis shows promising potential in tumor treatment; however, factors that compromise the efficiency of the Fenton catalyst have limited its therapeutic effectiveness. We developed a polydopamine-based nanoplatform constructed with ferric ion and sulfasalazine-loaded nanoparticles (Fe(III)PP@SAS NPs) for dual-functional ferrotherapy strategy of "sword and shield" through enhanced Fenton reaction and inactivation of glutathione peroxidase 4 (GPX4), respectively. Both the Fenton reaction-based hydroxyl radical (·OH) production and sulfasalazine-driven GPX4 inhibition induced ferroptotic cell death, thus achieving synergistic cancer therapy. Near-infrared light irradiation and acidic tumor microenvironment enhanced the release of ferric ions and sulfasalazine from the Fe(III)PP@SAS NPs. In addition, the released iron ions underwent valence state change due to Fenton reaction and thus provided a supplementary T1-weighted signal for in situ visualization of the tumor based on magnetic resonance imaging. The Fe(III)PP@SAS NPs exhibited high pro-ferroptosis performance by utilizing ·OH radicals as a "sword" to attack cancer cells and the GPX4 inhibitor to break down the "shield" of cancer cells, thus showing potential for cancer treatment. STATEMENT OF SIGNIFICANCE: Several strategies of cancer therapy based on ferroptosis have emerged in recent years, which have provided new insights into designing materials for therapeutic applications. The antitumor efficacy of ferroptosis is, however, still unsatisfactory, mainly because of insufficient intracellular pro-ferroptotic stimuli. In the current study, we report a multifunctional theranostic nanoplatform, namely Fe(III)PP@SAS, with three-fold synergistic effect; this nanoplatform has excellent theranostic potential with multifunctional ferrotherapy.

A DFX-based iron nanochelator for cancer therapy

Cancer-Erythrocyte Membrane-Mimicking Fe3O4 Nanoparticles and DHJS for Ferroptosis/Immunotherapy Synergism in Tumors.

Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine

Ferrous Ions Doped Calcium Carbonate Nanoparticles Potentiate Chemotherapy by Inducing Ferroptosis.

Fe3O4‐Incorporated Metal‐Organic Framework for Chemo/Ferroptosis Synergistic Anti‐Tumor via the Enhanced Chemodynamic Therapy

Iron (II)-based metal-organic framework nanozyme for boosting tumor ferroptosis through inhibiting DNA damage repair and system Xc-

Fe-Mediated Self-Assembled Nanodrug for Tumor Microenvironment Activated Synergistic Ferroptosis-Based-Chemodynamic/Chemo Therapy and Magnetic Resonance Imaging

Peptidomimetic-liganded Gold Nanoclusters for Controlled Iron Delivery and Synergistic Suppression of Tumor Growth

Metal-Free Nanocomposites with Endogenous Labile Iron Pool Disturbing Capacity for Tumor Therapy Through Synergetic Stock Depletion and Supply Blockage Strategy

Multi-Enzyme Cascade-Triggered Nitric Oxide Release Nanoplatform Combined with Chemo Starvation-like Therapy for Multidrug-Resistant Cancers

An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells

In vitro studies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics

2D-ultrathin MXene/DOXjade platform for iron chelation chemo-photothermal therapy

Nanovesicle-templated Nanogel: A Dual-Modal Platform Integrating Intracellular Iron Homeostasis Disruption for Ferroptosis and MRI-guided Tumor Diagnosis

Fe 3+ -DOX-Mediated Self-Assembled Nanolipids for Tumor Microenvironment Activated Synergistic Ferroptotic-Chemo Therapy Assisted with MR-imaging

Mitochondrially targeted deferasirox kills cancer cells simultaneous iron deprivation and ferroptosis induction

Magnetically Guided Delivery of DHA and Fe Ions for Enhanced Cancer Therapy Based on Ph-Responsive Degradation of DHA-loaded Fe 3 O 4 @C@mil-100(Fe) Nanoparticles

Engineering iron-based nanomaterials for breast cancer therapy associated with ferroptosis

Highly selective and effective ferroptosis liposomal nanodrugs for synergistic antitumor therapy

Iron Ion and Sulfasalazine-Loaded Polydopamine Nanoparticles for Fenton Reaction and Glutathione Peroxidase 4 Inactivation for Enhanced Cancer Ferrotherapy.

Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal-Organic-Framework-Coated Magnetic Nanoparticles